198 related articles for article (PubMed ID: 14715044)
1. Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis.
Waugh J; Keating GM
Drugs Aging; 2004; 21(1):55-64; discussion 65-6. PubMed ID: 14715044
[TBL] [Abstract][Full Text] [Related]
2. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.
Blondeau JM
Drugs; 2004; 64(6):611-28. PubMed ID: 15018591
[TBL] [Abstract][Full Text] [Related]
3. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
4. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis.
Talan DA; Klimberg IW; Nicolle LE; Song J; Kowalsky SF; Church DA
J Urol; 2004 Feb; 171(2 Pt 1):734-9. PubMed ID: 14713799
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women.
Fourcroy JL; Berner B; Chiang YK; Cramer M; Rowe L; Shore N
Antimicrob Agents Chemother; 2005 Oct; 49(10):4137-43. PubMed ID: 16189090
[TBL] [Abstract][Full Text] [Related]
6. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.
Henry DC; Bettis RB; Riffer E; Haverstock DC; Kowalsky SF; Manning K; Hamed KA; Church DA
Clin Ther; 2002 Dec; 24(12):2088-104. PubMed ID: 12581547
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis.
Cox CE; Marbury TC; Pittman WG; Brown GL; Auerbach SM; Fox BC; Yang JY
Clin Ther; 2002 Feb; 24(2):223-36. PubMed ID: 11911553
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections.
Mirone V; Fusco F; Taglialatela D; Verze P; Di Vito C; Lotti T; Imbimbo C;
J Chemother; 2009 Dec; 21(6):651-60. PubMed ID: 20071289
[TBL] [Abstract][Full Text] [Related]
9. The treatment of urinary tract infections and use of ciprofloxacin extended release.
Hickerson AD; Carson CC
Expert Opin Investig Drugs; 2006 May; 15(5):519-32. PubMed ID: 16634690
[TBL] [Abstract][Full Text] [Related]
10. Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections.
Wagenlehner F; Nowicki M; Bentley C; Lückermann M; Wohlert S; Fischer C; Vente A; Naber K; Dalhoff A
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339395
[TBL] [Abstract][Full Text] [Related]
11. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections.
Naber KG; Bartnicki A; Bischoff W; Hanus M; Milutinovic S; van Belle F; Schönwald S; Weitz P; Ankel-Fuchs D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S41-53. PubMed ID: 15037328
[TBL] [Abstract][Full Text] [Related]
12. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
Patel SS; Balfour JA; Bryson HM
Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
[TBL] [Abstract][Full Text] [Related]
13. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.
Klimberg I; Shockey G; Ellison H; Fuller-Jonap F; Colgan R; Song J; Keating K; Cyrus P
Curr Med Res Opin; 2005 Aug; 21(8):1241-50. PubMed ID: 16083534
[TBL] [Abstract][Full Text] [Related]
14. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial.
Mombelli G; Pezzoli R; Pinoja-Lutz G; Monotti R; Marone C; Franciolli M
Arch Intern Med; 1999 Jan; 159(1):53-8. PubMed ID: 9892331
[TBL] [Abstract][Full Text] [Related]
15. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy.
Perfetto EM; Keating K; Merchant S; Nichols BR
J Manag Care Pharm; 2004; 10(1):17-25. PubMed ID: 14720102
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
Langtry HD; Lamb HM
Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
[TBL] [Abstract][Full Text] [Related]
17. Which fluoroquinolones are suitable for the treatment of urinary tract infections?
Naber KG
Int J Antimicrob Agents; 2001 Apr; 17(4):331-41. PubMed ID: 11295418
[TBL] [Abstract][Full Text] [Related]
18. Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosa.
Saltzstein D; Wachs B; Perroncel R; Benson A; Herrington J; Haverstock D; Pertel P
J Chemother; 2007 Dec; 19(6):694-702. PubMed ID: 18230553
[TBL] [Abstract][Full Text] [Related]
19. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
[TBL] [Abstract][Full Text] [Related]
20. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Wagenlehner FM; Umeh O; Steenbergen J; Yuan G; Darouiche RO
Lancet; 2015 May; 385(9981):1949-56. PubMed ID: 25931244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
